Close Menu

Books in a Library

FL Affonso Fonseca

Safety and Efficacy KollaGen II-xs: A 60-day Clinical Trial

Issue: 
DOI: 
10.7727/wimj.2016.293
Pages: 
69-72
Synopsis: 
KollaGen II-xsTM is a dietary supplement that may be beneficial for patients suffering from degenerative joint diseases. The present single-centre clinical trial investigated the safety and efficacy of this new avian sternal collagen type II hydrolysate.

ABSTRACT

Objective: To investigate the safety and efficacy of an avian sternal collagen type II hydrolysate, KollaGen II-xs™.

Methods: A goniometer was used to measure the range of motion, a pain scale (Borg) was applied to subjectively percept the pain, and a properly calibrated sphygmomanometer was utilized to evaluate muscle strength.

Accepted: 
12 Aug, 2016
PDF Attachment: 
Journal Sections: 
e-Published: 12 Aug, 2016
Subscribe to RSS - FL Affonso Fonseca
Top of Page